 Gonadotropin-Releasing Hormone
"Gonadotropin-Releasing Hormone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A decapeptide that stimulates the synthesis and secretion of both pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE. GnRH is produced by neurons in the septum PREOPTIC AREA of the HYPOTHALAMUS and released into the pituitary portal blood, leading to stimulation of GONADOTROPHS in the ANTERIOR PITUITARY GLAND.
| Descriptor ID |
D007987
|
| MeSH Number(s) |
D06.472.699.327.740.320 D12.644.400.400.740.320 D12.644.456.460 D12.644.548.365.740.320 D12.776.631.650.405.740.320
|
| Concept/Terms |
Gonadotropin-Releasing Hormone- Gonadotropin-Releasing Hormone
- Gonadotropin Releasing Hormone
- Gn-RH
- Gonadoliberin
- LHFSH Releasing Hormone
- Releasing Hormone, LHFSH
- LH-RH
- LFRH
- LH-Releasing Hormone
- LH Releasing Hormone
- LH-FSH Releasing Hormone
- LH FSH Releasing Hormone
- LHFSHRH
- LHRH
- Luliberin
- Gonadorelin
- Luteinizing Hormone-Releasing Hormone
- Luteinizing Hormone Releasing Hormone
- FSH-Releasing Hormone
- FSH Releasing Hormone
- GnRH
|
Below are MeSH descriptors whose meaning is more general than "Gonadotropin-Releasing Hormone".
Below are MeSH descriptors whose meaning is more specific than "Gonadotropin-Releasing Hormone".
This graph shows the total number of publications written about "Gonadotropin-Releasing Hormone" by people in this website by year, and whether "Gonadotropin-Releasing Hormone" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1989 | 5 | 1 | 6 | | 1990 | 7 | 1 | 8 | | 1991 | 1 | 0 | 1 | | 1992 | 3 | 2 | 5 | | 1993 | 5 | 0 | 5 | | 1994 | 5 | 1 | 6 | | 1995 | 5 | 0 | 5 | | 1996 | 4 | 0 | 4 | | 1997 | 3 | 1 | 4 | | 1998 | 1 | 1 | 2 | | 1999 | 2 | 0 | 2 | | 2000 | 4 | 1 | 5 | | 2001 | 1 | 1 | 2 | | 2002 | 4 | 1 | 5 | | 2003 | 5 | 1 | 6 | | 2004 | 4 | 0 | 4 | | 2005 | 4 | 1 | 5 | | 2006 | 1 | 0 | 1 | | 2007 | 5 | 2 | 7 | | 2008 | 6 | 0 | 6 | | 2009 | 2 | 0 | 2 | | 2010 | 4 | 2 | 6 | | 2011 | 5 | 1 | 6 | | 2012 | 3 | 2 | 5 | | 2013 | 2 | 2 | 4 | | 2014 | 1 | 3 | 4 | | 2015 | 3 | 3 | 6 | | 2016 | 3 | 1 | 4 | | 2017 | 2 | 0 | 2 | | 2018 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Gonadotropin-Releasing Hormone" by people in Profiles.
-
Melanson EL, Lyden K, Gibbons E, Gavin KM, Wolfe P, Wierman ME, Schwartz RS, Kohrt WM. Influence of Estradiol Status on Physical Activity in Premenopausal Women. Med Sci Sports Exerc. 2018 08; 50(8):1704-1709.
-
Tsai PS. Gonadotropin-releasing hormone by any other name would smell as sweet. Gen Comp Endocrinol. 2018 08 01; 264:58-63.
-
Xu J, Feng C, Miao Y. Evaluation of novel 111In-labeled gonadotropin-releasing hormone peptides for human prostate cancer imaging. Bioorg Med Chem Lett. 2017 10 15; 27(20):4647-4651.
-
Washino S, Hirai M, Saito K, Kobayashi Y, Arai Y, Miyagawa T. Impact of Androgen Deprivation Therapy on Volume Reduction and Lower Urinary Tract Symptoms in Patients with Prostate Cancer. Low Urin Tract Symptoms. 2018 Jan; 10(1):57-63.
-
Bian SX, Kuban DA, Levy LB, Oh J, Choi S, McGuire SE, Frank SJ, Mahmood U, Nguyen PL, Pugh TJ, Lee AK, Hoffman KE. The Influence of Age and Comorbidity on the Benefit of Adding Androgen Deprivation to Dose-escalated Radiation in Men With Intermediate-risk Prostate Cancer. Am J Clin Oncol. 2016 08; 39(4):368-73.
-
Plachetzki DC, Tsai PS, Kavanaugh SI, Sower SA. Ancient origins of metazoan gonadotropin-releasing hormone and their receptors revealed by phylogenomic analyses. Gen Comp Endocrinol. 2016 08 01; 234:10-9.
-
Phelan R, Mann E, Napurski C, DeFor TE, Petryk A, Miller WP, Wagner JE, Verneris MR, Smith AR. Ovarian function after hematopoietic cell transplantation: a descriptive study following the use of GnRH agonists for myeloablative conditioning and observation only for reduced-intensity conditioning. Bone Marrow Transplant. 2016 Oct; 51(10):1369-1375.
-
Shore ND, Chu F, Moul J, Saltzstein D, Concepcion R, McLane JA, Atkinson S, Yang A, Crawford ED. Polymer-delivered subcutaneous leuprolide acetate formulations achieve and maintain castrate concentrations of testosterone in four open-label studies in patients with advanced prostate cancer. BJU Int. 2017 Feb; 119(2):239-244.
-
Shea KL, Gavin KM, Melanson EL, Gibbons E, Stavros A, Wolfe P, Kittelson JM, Vondracek SF, Schwartz RS, Wierman ME, Kohrt WM. Body composition and bone mineral density after ovarian hormone suppression with or without estradiol treatment. Menopause. 2015 Oct; 22(10):1045-52.
-
Al-Safi ZA, Liu H, Carlson NE, Chosich J, Lesh J, Robledo C, Bradford AP, Gee NA, Phang T, Santoro N, Kohrt W, Polotsky AJ. Estradiol Priming Improves Gonadotrope Sensitivity and Pro-Inflammatory Cytokines in Obese Women. J Clin Endocrinol Metab. 2015 Nov; 100(11):4372-81.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|